Dialysis therapies for end-stage renal disease

Seminars in Dialysis

Volumn 15, Issue 4, 2002, Pages 220-226

  Gokal, Ram ^a,b   Hutchison, Alastair ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; KIDNEY FUNCTION TEST; MALE; METHODOLOGY; MORTALITY; PERITONEAL DIALYSIS; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PERITONEAL DIALYSIS; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036652938     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2002.00064.x     Document Type: Review

References (48)

1. U.S. Renal Data System: USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2001
2. Feest TG, Mistry CD, Grimes DS, Mallick NP: Incidence of advanced chronic renal failure and the need for end-stage renal replacement therapy. Br Med J 301:897-900, 1990
3. McGeown MG: Prevalence of advanced renal failure in Northern Ireland. Br Med J 301:900-903, 1990
4. Roderick P, Jones I, Raleigh VS, McGeown MG, Mallick NP: Population need for renal replacement therapy in Thames regions: ethnic dimension. Br Med J 309:1111-1114, 1994
5. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, Riella MC, Rottembourg J, Stewart JH: ESRD modality selection into the 21st century: the importance of non medical factors. ASAIO J 43(3):143-150, 1997
6. Popovich RP, Monereif JW, Decherd JF, Bomar JB, Pyle WK: The definition of a novel portable/wearable equilibrium dialysis technique [abstract]. Trans Am Soc Artif Intern Organs 5:64, 1976
7. Krediet RT: The physiology of peritoneal solute transport and ultrafiltration. In: The Textbook of Peritoneal Dialysis, 2nd ed. Dordrecht: Kluwer Academic, 2000:135-172
8. Twardowski ZJ: Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7(2-3):95-108, 1989
9. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9:1285-1293, 1998
10. Coles G: Have we underestimated the importance of fluid balance for survival of PD patients? Perit Dial Int 17:321-326, 1997
11. Churchill D, Taylor DW, Kesheviah PR. CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcome. J Am Soc Nephrol 7:198-207, 1996
12. National Kidney Foundation: K DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 37(1 suppl 1):S65-S136, 2001
13. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomised, controlled study. J Am Soc Nephrol 13:455-461, 2002
14. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20:396-411, 2000
15. Ates K, Koc R, Nergizoglu G, Erturk S, Keven K, Sen A, Karatan O: The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int 20:220-226, 2000
16. Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis. J Am Soc Nephrol 11:2403-2408, 1996
17. Piraino B: Staphylococcus aureus infections in dialysis patients: focus on prevention. ASAIO J 46(6):S13-S17, 2000
18. Davey P, Craig AM, Hau C, Malek MJ: Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial. Antimicrob Chemoter 43:105-112, 1999
19. Nakayama M, Kawaguchi Y, Yamada K, et al.: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
20. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
21. Hendriks PM, Ho dac Pannekeet MM, van Gulik TM, et al.: Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 17:136-143, 1997
22. Selgas R, Bajo MA, Castro MJ, del Peso G, Aguilera A, Fernandez-Perpen A, Cirugeda A, Sanchez-Tomero JA: Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis. Perit Dial Int 20:631-636, 2000
23. Mistry CD, Gokal R, Peers E, Midas Study Group: A randomised multicentre clinical trial comparing isosmolar dextrin 20 with hyperosmolar glucose solutions in continuous ambulatory peritoneal dialysis (CAPD): a 6 month study. Kidney Int 46:496-503, 1994
24. Fenton SSA, Schaulbel DF, Desmeules M, et al.: Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
25. Gokal R, Figueras M, Olle A, Rovira J, Badia X: Outcomes in peritoneal dialysis and haemodialysis a comparative assessment of survival and quality of life. Nephrol Dial Transplant 14(suppl):624-630, 1999
26. Maiorca R, Cancarini GC, Zubani R, Movilli E, Brunori G: Differing dialysis treatment strategies and outcome. Nephrol Dial Transplant 11(suppl):2134-2139, 1996
27. Fox JG, Fowler I, Boulton-Jones JM: Audit of a decade of continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 8:240-243, 1993
28. Gokal R: New strategies for peritoneal dialysis solutions. Nephrol Dial Transplant 12(suppl I):74-77, 1997
29. Coles G, Williams JD: What is the place of peritoneal dialysis in the integrated treatment of renal failure? Kidney Int 54:2234-2240, 1998
30. Bleyer AJ, Burkart JM, Russell GB, Adams PL: Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 10:154-159, 1999
31. The Renal Association: Treatment of adult patients with renal failure. Recommended standards and audit measures. 2nd edition. London: Renal Association and Royal College of Physicians, 1997
32. Goodkin DA, Mapes DL, Held PJ: The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 14(3):157-159, 2001
33. Innes A, Charra B, Burden RP, Morgan AG, Laurent G: The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 14(4):919-922, 1999
34. The National Cooperative Dialysis Study. Kidney Int (13)Suppl:S1-122, 1983
35. Vos PF, Zilch O, Kooistra MP: Clinical outcome of daily dialysis. Am J Kidney Dis 37(1 Supp2):S99-S102, 2001
36. Schreiber M-J Jr: Clinical case-based approach to understanding intradialytic hypotension. Am J Kidney Dis 38(4 Suppl 4):S37-S47, 2001
37. Stiller S, Bonnie-Schorn E, Grassmann A, Uhlenbusch-Korwer I, Mann H: A critical review of sodium profiling for hemodialysis. Semin Dial 14(5):337-347, 2001
38. Gunal A-I, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, Basci A: Strict volume contril normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37(3):588-593, 2001
39. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607-617, 1998
40. Raggi P: Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients. Clin Nephrol 54(4):325-333, 2000
41. Fournier A, Barsoum J, Fickl R, Oprisiu R, El-Esper N, Moriniere P. Sevelamer, Ca x P product and vilamin D. Nephrol Dia-Transplant 16(2):429-430, 2001
42. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15(7):953-960, 2000
43. Rocco M, Soucie JM, Pastan S, McClellan WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 58(1):446-457, 2000
44. Tanna MM, Vonesh EF, Korbet SM: Patient survival among incident peritioneal dialysis and hemodialysis patients in an urban setting. Am J Kidney Dis 36(6):1175-1182, 2000
45. Ohashi H, Oda H, Ohno M, Sakata S: Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of left ventricular hypertrophy and diabetic nephropathy. Adv Perit Dial 19:1587-1590, 1999
46. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33(3):507-517, 1999
47. Gokal R: Early start to peritoneal dialysis: to start or not to start? Perit Dial Int 20(4):386-389, 2000
48. Gokal R: Taking peritoneal dialysis beyond the year 2000. Perit Dial Int 19(Suppl 3):S35-S42, 1999